Lpl Financial LLC Biocryst Pharmaceuticals Inc Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Lpl Financial LLC holds 15,872 shares of BCRX stock, worth $123,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,872

Previous 17,632 9.98%

Holding current value

$123,484

Previous $108,000 11.11%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$6.41 - $8.69 $11,281 - $15,294	-1,760 Reduced 9.98%	15,872 $120,000
Q2 2024 Aug 07, 2024	BUY	$4.13 - $6.79 $5,017 - $8,249	1,215 Added 7.4%	17,632 $108,000
Q1 2024 May 10, 2024	SELL	$4.89 - $7.65 $4,987 - $7,803	-1,020 Reduced 5.85%	16,417 $83,000
Q4 2023 Feb 14, 2024	SELL	$4.98 - $6.77 $6,175 - $8,394	-1,240 Reduced 6.64%	17,437 $104,000
Q3 2023 Nov 13, 2023	SELL	$6.71 - $7.92 $67,321 - $79,461	-10,033 Reduced 34.95%	18,677 $132,000
Q2 2023 Jul 31, 2023	BUY	$6.96 - $8.81 $9,298 - $11,770	1,336 Added 4.88%	28,710 $202,000
Q1 2023 May 10, 2023	BUY	$7.94 - $11.84 $24,367 - $36,336	3,069 Added 12.63%	27,374 $228,000
Q4 2022 Feb 07, 2023	BUY	$10.5 - $14.2 $23,394 - $31,637	2,228 Added 10.09%	24,305 $279,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $8,826 - $12,114	818 Added 3.85%	22,077 $278,000
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $47,931 - $108,621	-6,075 Reduced 22.23%	21,259 $225,000
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $28,483 - $48,688	2,464 Added 9.91%	27,334 $444,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $431,492 - $596,678	-38,595 Reduced 60.81%	24,870 $344,000
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $208,219 - $258,625	-14,653 Reduced 18.76%	63,465 $912,000
Q2 2021 Aug 13, 2021	BUY	$9.5 - $17.24 $340,204 - $617,381	35,811 Added 84.65%	78,118 $1.24 Million
Q1 2021 May 14, 2021	BUY	$7.37 - $13.61 $169,053 - $312,186	22,938 Added 118.43%	42,307 $430,000
Q4 2020 Feb 12, 2021	SELL	$3.37 - $8.61 $235 - $602	-70 Reduced 0.36%	19,369 $144,000
Q3 2020 Nov 09, 2020	BUY	$3.43 - $5.53 $66,675 - $107,497	19,439 New	19,439 $67,000
Q3 2019 Nov 13, 2019	SELL	$2.5 - $3.73 $81,832 - $122,094	-32,733 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$2.91 - $9.15 $5,820 - $18,300	-2,000 Reduced 5.76%	32,733 $124,000
Q1 2019 May 08, 2019	BUY	$7.38 - $9.72 $11,808 - $15,552	1,600 Added 4.83%	34,733 $283,000
Q4 2018 Feb 07, 2019	SELL	$6.51 - $9.6 $11,392 - $16,800	-1,750 Reduced 5.02%	33,133 $267,000
Q3 2018 Nov 14, 2018	SELL	$5.52 - $7.99 $5,520 - $7,990	-1,000 Reduced 2.79%	34,883 $266,000
Q2 2018 Aug 14, 2018	BUY	$4.6 - $6.52 $13,339 - $18,908	2,900 Added 8.79%	35,883 $206,000
Q1 2018 May 15, 2018	SELL	$4.35 - $5.82 $7,286 - $9,748	-1,675 Reduced 4.83%	32,983 $157,000
Q4 2017 Feb 14, 2018	BUY	$4.16 - $5.33 $144,177 - $184,727	34,658	34,658 $170,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Biocryst Pharmaceuticals Inc Transaction History